Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05526755
Title A Study of 5 Years of Adjuvant Osimertinib in Completely Resected Epidermal Growth Factor Receptor Mutation (EGFRm) Non-small Cell Lung Carcinoma (NSCLC) (TARGET)
Acronym TARGET
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | GBR | ESP

Facility Status City State Zip Country Details
Research Site Santa Rosa California 95403 United States Details
Research Site Las Vegas Nevada 89169 United States Details
Research Site White Plains New York 10601 United States Details
Research Site Hong Kong 150001 Hong Kong Details
Research Site Hong Kong Hong Kong Details
Research Site Avellino 83100 Italy Details
Research Site Brescia 25123 Italy Details
Research Site Lecce 73100 Italy Details
Research Site Milano 20141 Italy Details
Research Site Napoli 80131 Italy Details
Research Site Palermo 90146 Italy Details
Research Site Peschiera Del Garda 37019 Italy Details
Research Site Reggio Emilia 42123 Italy Details
Research Site Sondrio 23100 Italy Details
Research Site Terni 05100 Italy Details
Research Site Udine 33100 Italy Details
Research Site Busan 48108 Korea, Republic of Details
Research Site Busan 49241 Korea, Republic of Details
Research Site Cheongju-si 28644 Korea, Republic of Details
Research Site Daejeon 35015 Korea, Republic of Details
Research Site Goyang-si 410-769 Korea, Republic of Details
Research Site Gyeonggi-do 13620 Korea, Republic of Details
Research Site Incheon 21565 Korea, Republic of Details
Research Site Seongnam-si 13496 Korea, Republic of Details
Research Site Seoul 03080 Korea, Republic of Details
Research Site Seoul 03722 Korea, Republic of Details
Research Site Seoul 05030 Korea, Republic of Details
Research Site Seoul 05505 Korea, Republic of Details
Research Site Seoul 06273 Korea, Republic of Details
Research Site Seoul 06351 Korea, Republic of Details
Research Site Seoul 06591 Korea, Republic of Details
Research Site Kuala Lumpur 59100 Malaysia Details
Research Site Kuantan 25100 Malaysia Details
Research Site Kuching 93586 Malaysia Details
Research Site Cebu 6000 Philippines Details
Research Site Manila 1000 Philippines Details
Research Site Quezon City 1100 Philippines Details
Research Site Singapore 119074 Singapore Details
Research Site Badalona 08013 Spain Details
Research Site Barcelona 08036 Spain Details
Research Site Bilbao 48013 Spain Details
Research Site Granada 18014 Spain Details
Research Site L'Hospitalet de Llobregat 08907 Spain Details
Research Site Madrid 28007 Spain Details
Research Site Sevilla 41009 Spain Details
Research Site Valencia 46026 Spain Details
Research Site Hualien 970 Taiwan Details
Research Site Kaohsiung City 833401 Taiwan Details
Research Site Kaohsiung 82445 Taiwan Details
Research Site Taichung 40705 Taiwan Details
Research Site Taipei 10449 Taiwan Details
Research Site Bangkok 10700 Thailand Details
Research Site Songkhla 90110 Thailand Details
Research Site London SW3 6JJ United Kingdom Details
Research Site Nottingham NG5 1PB United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field